Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
7.68
-0.22 (-2.78%)
At close: Feb 27, 2026, 4:00 PM EST
7.70
+0.02 (0.26%)
After-hours: Feb 27, 2026, 7:57 PM EST
Upstream Bio Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Upstream Bio stock have an average target of 46, with a low estimate of 40 and a high estimate of 51. The average target predicts an increase of 498.96% from the current stock price of 7.68.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 18, 2025.
Analyst Ratings
The average analyst rating for Upstream Bio stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 1 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 2 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Initiates $51 | Buy | Initiates | $51 | +564.06% | Dec 18, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $40 | Buy | Initiates | $40 | +420.83% | Nov 18, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $47 | Strong Buy | Initiates | $47 | +511.98% | Oct 14, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +394.79% | Nov 5, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 5, 2024 |
Financial Forecast
Revenue This Year
2.79M
from 2.37M
Increased by 17.89%
Revenue Next Year
1.55M
from 2.79M
Decreased by -44.56%
EPS This Year
-2.60
from -5.58
EPS Next Year
-3.18
from -2.60
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.2M | 3.7M | ||||
| Avg | 2.8M | 1.5M | ||||
| Low | 2.1M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 32.9% | 31.5% | ||||
| Avg | 17.9% | -44.6% | ||||
| Low | -9.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.55 | -2.71 | ||||
| Avg | -2.60 | -3.18 | ||||
| Low | -2.72 | -3.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.